Quantbot Technologies Reduces Stake in Cardinal Health

Hedge fund lowers position in healthcare distribution company by nearly 80%

Published on Mar. 3, 2026

Got story updates? Submit your updates here. ›

Quantbot Technologies LP, a hedge fund, has reduced its stake in Cardinal Health, Inc. (NYSE:CAH) by 79.7% in the third quarter, according to a recent SEC filing. The firm now owns 22,537 shares of the healthcare distribution company's stock, down from 111,248 shares previously.

Why it matters

This reduction in Quantbot's position in Cardinal Health is notable as it suggests the hedge fund has become less bullish on the company's prospects. Cardinal Health is a major player in the healthcare distribution industry, so changes in institutional ownership can signal broader market sentiment.

The details

According to the SEC filing, Quantbot Technologies sold 88,711 shares of Cardinal Health during the third quarter, lowering its total position to 22,537 shares worth $3.5 million. The hedge fund cited unspecified reasons for the reduction in its Cardinal Health holdings.

  • Quantbot Technologies filed the 13F report disclosing the stake reduction on March 3, 2026.
  • The stake reduction occurred in the third quarter of the previous year.

The players

Quantbot Technologies LP

A hedge fund that has reduced its position in Cardinal Health, Inc.

Cardinal Health, Inc.

A major healthcare distribution company based in Dublin, Ohio.

Got photos? Submit your photos here. ›

The takeaway

The reduction in Quantbot's stake in Cardinal Health suggests the hedge fund has become less bullish on the healthcare distributor's prospects, which could signal broader market sentiment around the company. However, without further details on Quantbot's rationale, it's difficult to draw firm conclusions about the long-term outlook for Cardinal Health.